The document discusses the Latin American Group of Lymphomas (GELL) and its efforts to standardize lymphoma diagnosis, treatment and follow-up care across Latin America. It notes that Latin America is a unique and diverse region with significant differences in lymphoma distributions and risk factors between countries. GELL was formed in 2016 with the goal of presenting real regional data as a group rather than individual countries. Initial efforts involved six countries and publishing results. GELL has since established legal status, developed consensus guidelines, presented findings at international conferences, and is now collecting new epidemiological data on follicular lymphoma to further characterize the disease burden in Latin America.